
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.07 | 3.48258706468 | 2.01 | 2.12 | 1.99 | 134446 | 2.077515 | CS |
4 | 0.1 | 5.05050505051 | 1.98 | 2.12 | 1.815 | 472295 | 1.95155199 | CS |
12 | 0.43 | 26.0606060606 | 1.65 | 2.12 | 1.64 | 316153 | 1.9250566 | CS |
26 | 0.03 | 1.46341463415 | 2.05 | 2.12 | 1.34 | 249499 | 1.84248007 | CS |
52 | 0.31 | 17.5141242938 | 1.77 | 2.15 | 1.34 | 360145 | 1.82105217 | CS |
156 | -11.68 | -84.8837209302 | 13.76 | 24.42 | 1.34 | 220048 | 5.85788084 | CS |
260 | -16.68 | -88.9125799574 | 18.76 | 24.42 | 1.34 | 221577 | 6.33026963 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.